Anti-PD-L1 immunotherapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-PD-L1 immunotherapy, covering 2025-01-15 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer